Incyte
INCY
#975
Rank
โ‚ฌ22.15 B
Marketcap
108,67ย โ‚ฌ
Share price
1.72%
Change (1 day)
18.51%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of September 2026 : โ‚ฌ1.46 Billion

According to Incyte's latest financial reports the company's total liabilities are โ‚ฌ1.46 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ1.44 B5.04%
2022-12-31โ‚ฌ1.37 B33.49%
2021-12-31โ‚ฌ1.02 B33.05%
2020-12-31โ‚ฌ0.77 B4.41%
2019-12-31โ‚ฌ0.73 B17.52%
2018-12-31โ‚ฌ0.62 B12.35%
2017-12-31โ‚ฌ0.56 B-51.68%
2016-12-31โ‚ฌ1.15 B51.54%
2015-12-31โ‚ฌ0.76 B5.93%
2014-12-31โ‚ฌ0.72 B21.2%
2013-12-31โ‚ฌ0.59 B55.92%
2012-12-31โ‚ฌ0.38 B-10.77%
2011-12-31โ‚ฌ0.42 B-1.51%
2010-12-31โ‚ฌ0.43 B-23.56%
2009-12-31โ‚ฌ0.56 B75.45%
2008-12-31โ‚ฌ0.32 B8.75%
2007-12-31โ‚ฌ0.29 B-10.31%
2006-12-31โ‚ฌ0.33 B0.04%
2005-12-31โ‚ฌ0.33 B2.78%
2004-12-31โ‚ฌ0.32 B80.67%
2003-12-31โ‚ฌ0.17 B-25.12%
2002-12-31โ‚ฌ0.23 B-20.49%
2001-12-31โ‚ฌ0.30 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
โ‚ฌ71.06 B 4,739.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ103.25 B 6,932.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ96.25 B 6,455.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ74.95 B 5,005.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ1.08 B-25.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
โ‚ฌ0.26 B-81.73%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚ฌ0.12 B-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
โ‚ฌ64.63 M-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚ฌ0.38 B-74.04%๐Ÿ‡บ๐Ÿ‡ธ USA